These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35949003)

  • 1. Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein.
    Jiang X; Sharma PP; Rathi B; Ji X; Hu L; Gao Z; Kang D; Wang Z; Xie M; Xu S; Zhang X; De Clercq E; Cocklin S; Pannecouque C; Dick A; Liu X; Zhan P
    J Med Virol; 2022 Dec; 94(12):5975-5986. PubMed ID: 35949003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
    Sun L; Huang T; Dick A; Meuser ME; Zalloum WA; Chen CH; Ding X; Gao P; Cocklin S; Lee KH; Zhan P; Liu X
    Eur J Med Chem; 2020 Mar; 190():112085. PubMed ID: 32066010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.
    Wu G; Zalloum WA; Meuser ME; Jing L; Kang D; Chen CH; Tian Y; Zhang F; Cocklin S; Lee KH; Liu X; Zhan P
    Eur J Med Chem; 2018 Oct; 158():478-492. PubMed ID: 30243152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors.
    Li J; Jiang X; Dick A; Prakash Sharma P; Chen CH; Rathi B; Kang D; Wang Z; Ji X; Lee KH; Cocklin S; Liu X; Zhan P
    Bioorg Med Chem; 2021 Oct; 48():116414. PubMed ID: 34562701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
    Zhang X; Sun L; Meuser ME; Zalloum WA; Xu S; Huang T; Cherukupalli S; Jiang X; Ding X; Tao Y; Kang D; De Clercq E; Pannecouque C; Dick A; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 226():113848. PubMed ID: 34592608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
    Sun L; Dick A; Meuser ME; Huang T; Zalloum WA; Chen CH; Cherukupalli S; Xu S; Ding X; Gao P; Kang D; De Clercq E; Pannecouque C; Cocklin S; Lee KH; Liu X; Zhan P
    J Med Chem; 2020 May; 63(9):4790-4810. PubMed ID: 32298111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Structure-Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction.
    Ji X; Li J; Sharma PP; Jiang X; Rathi B; Gao Z; Hu L; Kang D; De Clercq E; Cocklin S; Liu C; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
    Xu S; Sun L; Dick A; Zalloum WA; Huang T; Meuser ME; Zhang X; Tao Y; Cherukupalli S; Ding D; Ding X; Gao S; Jiang X; Kang D; De Clercq E; Pannecouque C; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2022 Jan; 227():113903. PubMed ID: 34653770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors.
    Jiang X; Wu G; Zalloum WA; Meuser ME; Dick A; Sun L; Chen CH; Kang D; Jing L; Jia R; Cocklin S; Lee KH; Liu X; Zhan P
    RSC Adv; 2019; 9(50):28961-28986. PubMed ID: 32089839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators.
    Xu S; Sun L; Zalloum WA; Huang T; Zhang X; Ding D; Shao X; Jiang X; Zhao F; Cocklin S; De Clercq E; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid.
    Chia T; Nakamura T; Amano M; Takamune N; Matsuoka M; Nakata H
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0103921. PubMed ID: 34228546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
    Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators.
    Zhang X; Sun L; Xu S; Shao X; Li Z; Ding D; Jiang X; Zhao S; Cocklin S; Clercq E; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly.
    Price AJ; Jacques DA; McEwan WA; Fletcher AJ; Essig S; Chin JW; Halambage UD; Aiken C; James LC
    PLoS Pathog; 2014 Oct; 10(10):e1004459. PubMed ID: 25356722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Broad-Spectrum Antiviral Molecule, Protoporphyrin IX, Acts as a Moderator of HIV-1 Capsid Assembly by Targeting the Capsid Hexamer.
    Zhang DW; Xie L; Xu XS; Li Y; Xu X
    Microbiol Spectr; 2023 Feb; 11(1):e0266322. PubMed ID: 36475726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.
    Saito A; Ferhadian D; Sowd GA; Serrao E; Shi J; Halambage UD; Teng S; Soto J; Siddiqui MA; Engelman AN; Aiken C; Yamashita M
    J Virol; 2016 Jun; 90(12):5808-5823. PubMed ID: 27076642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of HIV-1 capsid recognition by PF74 and CPSF6.
    Bhattacharya A; Alam SL; Fricke T; Zadrozny K; Sedzicki J; Taylor AB; Demeler B; Pornillos O; Ganser-Pornillos BK; Diaz-Griffero F; Ivanov DN; Yeager M
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18625-30. PubMed ID: 25518861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-Pathway Assembly: A Broad-Spectrum Mechanism of Action for Drugs That Undermine Controlled HIV-1 Viral Capsid Formation.
    Pak AJ; Grime JMA; Yu A; Voth GA
    J Am Chem Soc; 2019 Jul; 141(26):10214-10224. PubMed ID: 31244184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery and design of novel HIV-1 capsid modulators and future perspectives.
    Ding D; Xu S; Zhang X; Jiang X; Cocklin S; Dick A; Zhan P; Liu X
    Expert Opin Drug Discov; 2023 Jan; 18(1):5-12. PubMed ID: 36480372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.